etienna bio
The Etienna Dispatch

Progress from the category of one.

Etienna is building the first autologous fat-transfer product, the sole entry into a market delivered until now entirely as surgery. Subscribe for milestones, data as it clears, and the occasional deeper look at the science.

Occasional updates on the science and the company. No spam; unsubscribe anytime.

← Back to etiennabio.com